Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022795674> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2022795674 endingPage "50" @default.
- W2022795674 startingPage "41" @default.
- W2022795674 abstract "1. Mibefradil was compared with (+/-)-verapamil for effects on ischaemia- and reperfusion-induced ventricular fibrillation (VF), and the role of ischaemia-selective L-channel block was examined. Langendorff perfused rat hearts (n=12/group) were used. 2. Neither drug at up to 100 nM reduced the incidence of VF during 30 min regional ischaemia. 300 and 600 nM (+/-)-verapamil abolished VF (P<0. 05); mibefradil was effective only at 600 nM (P<0.05). Reperfusion-induced VF incidence was reduced only by 600 nM (+/-)-verapamil (P<0.05). Both drugs at >/=100 nM increased coronary flow (P<0.05) with a similar potency and maximum effectiveness. 3. In separate hearts perfused with Krebs' solution containing 3 mM K+ (the same as that used for arrhythmia studies) neither drug at up to 600 nM affected ventricular contractility. With K+ raised to 6 mM, (+/-)-verapamil >/=30 nM reduced developed pressure (P<0.05); mibefradil did so only at 600 nM (P<0.05). With K+ raised to 10 mM the effects of (+/-)-verapamil were further increased (P<0.05) and mibefradil became active at >/=100 nM (P<0.05). Likewise both drugs impaired diastolic relaxation, with raised K+ exacerbating the effects and (+/-)-verapamil being more potent and its effects more greatly exacerbated by K+. In contrast, when K+ was normal (3 mM), coronary flow was increased by each drug at >/=30 nM (P<0.05) indicating a marked vascular : myocardial selectivity. 4. In conclusion, mibefradil differed from (+/-)-verapamil in its myocardial effects only in terms of its lower potency. As mibefradil is the more potent T-channel blocker, the T-channel is unlikely to represent the molecular target for these effects. The K+ elevations that occur in the ischaemic milieu determine the ability of both drugs to block myocardial L-channels; this is sufficient to account for the drugs' actions on VF. Neither drug possesses sufficient selectivity for ischaemic myocardium versus blood vessels to permit efficacy (VF suppression without marked vasodilatation) and so inappropriate hypotension is likely to preclude the safe use of mibefradil (or similar analogue) in VF suppression, and explains the lack of clinical effectiveness of (+/-)-verapamil." @default.
- W2022795674 created "2016-06-24" @default.
- W2022795674 creator A5042693942 @default.
- W2022795674 creator A5061517390 @default.
- W2022795674 creator A5088914892 @default.
- W2022795674 date "1999-09-01" @default.
- W2022795674 modified "2023-10-08" @default.
- W2022795674 title "Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart" @default.
- W2022795674 cites W1935925824 @default.
- W2022795674 cites W1968598458 @default.
- W2022795674 cites W1977537669 @default.
- W2022795674 cites W1989324917 @default.
- W2022795674 cites W1989649753 @default.
- W2022795674 cites W1998445234 @default.
- W2022795674 cites W1998932167 @default.
- W2022795674 cites W2009837352 @default.
- W2022795674 cites W2012607597 @default.
- W2022795674 cites W2034877370 @default.
- W2022795674 cites W2035314238 @default.
- W2022795674 cites W2045351586 @default.
- W2022795674 cites W2045753865 @default.
- W2022795674 cites W2046802201 @default.
- W2022795674 cites W2059531850 @default.
- W2022795674 cites W2068253450 @default.
- W2022795674 cites W2070364693 @default.
- W2022795674 cites W2072302478 @default.
- W2022795674 cites W2073433070 @default.
- W2022795674 cites W2077357546 @default.
- W2022795674 cites W2077830033 @default.
- W2022795674 cites W2077936658 @default.
- W2022795674 cites W2081278908 @default.
- W2022795674 cites W2133488495 @default.
- W2022795674 cites W2194251361 @default.
- W2022795674 cites W2327035211 @default.
- W2022795674 cites W2330809401 @default.
- W2022795674 cites W2405982060 @default.
- W2022795674 cites W2614168425 @default.
- W2022795674 cites W4256032229 @default.
- W2022795674 cites W2263092743 @default.
- W2022795674 doi "https://doi.org/10.1038/sj.bjp.0702778" @default.
- W2022795674 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1571614" @default.
- W2022795674 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10498833" @default.
- W2022795674 hasPublicationYear "1999" @default.
- W2022795674 type Work @default.
- W2022795674 sameAs 2022795674 @default.
- W2022795674 citedByCount "28" @default.
- W2022795674 countsByYear W20227956742013 @default.
- W2022795674 countsByYear W20227956742014 @default.
- W2022795674 countsByYear W20227956742015 @default.
- W2022795674 countsByYear W20227956742016 @default.
- W2022795674 countsByYear W20227956742017 @default.
- W2022795674 countsByYear W20227956742020 @default.
- W2022795674 countsByYear W20227956742022 @default.
- W2022795674 crossrefType "journal-article" @default.
- W2022795674 hasAuthorship W2022795674A5042693942 @default.
- W2022795674 hasAuthorship W2022795674A5061517390 @default.
- W2022795674 hasAuthorship W2022795674A5088914892 @default.
- W2022795674 hasBestOaLocation W20227956741 @default.
- W2022795674 hasConcept C126322002 @default.
- W2022795674 hasConcept C164705383 @default.
- W2022795674 hasConcept C2777022698 @default.
- W2022795674 hasConcept C2778673320 @default.
- W2022795674 hasConcept C39133596 @default.
- W2022795674 hasConcept C519063684 @default.
- W2022795674 hasConcept C541997718 @default.
- W2022795674 hasConcept C71924100 @default.
- W2022795674 hasConcept C85520022 @default.
- W2022795674 hasConceptScore W2022795674C126322002 @default.
- W2022795674 hasConceptScore W2022795674C164705383 @default.
- W2022795674 hasConceptScore W2022795674C2777022698 @default.
- W2022795674 hasConceptScore W2022795674C2778673320 @default.
- W2022795674 hasConceptScore W2022795674C39133596 @default.
- W2022795674 hasConceptScore W2022795674C519063684 @default.
- W2022795674 hasConceptScore W2022795674C541997718 @default.
- W2022795674 hasConceptScore W2022795674C71924100 @default.
- W2022795674 hasConceptScore W2022795674C85520022 @default.
- W2022795674 hasIssue "1" @default.
- W2022795674 hasLocation W20227956741 @default.
- W2022795674 hasLocation W20227956742 @default.
- W2022795674 hasLocation W20227956743 @default.
- W2022795674 hasLocation W20227956744 @default.
- W2022795674 hasOpenAccess W2022795674 @default.
- W2022795674 hasPrimaryLocation W20227956741 @default.
- W2022795674 hasRelatedWork W1531601525 @default.
- W2022795674 hasRelatedWork W1785063574 @default.
- W2022795674 hasRelatedWork W190250366 @default.
- W2022795674 hasRelatedWork W2758277628 @default.
- W2022795674 hasRelatedWork W2935909890 @default.
- W2022795674 hasRelatedWork W2948807893 @default.
- W2022795674 hasRelatedWork W3173606202 @default.
- W2022795674 hasRelatedWork W3183948672 @default.
- W2022795674 hasRelatedWork W2778153218 @default.
- W2022795674 hasRelatedWork W3110381201 @default.
- W2022795674 hasVolume "128" @default.
- W2022795674 isParatext "false" @default.
- W2022795674 isRetracted "false" @default.
- W2022795674 magId "2022795674" @default.
- W2022795674 workType "article" @default.